Opendata, web and dolomites

m-RESIST

Mobile Therapeutic Attention for Patients with Treatment Resistant Schizophrenia

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "m-RESIST" data sheet

The following table provides information about the project.

Coordinator
FUNDACIO TICSALUT 

Organization address
address: C ERNEST LLUCH 32 Planta 6 Porta 4 TECNOCAMPUS MATARO MARESME TORRE TCM 3
city: MATARO BARCELONA
postcode: 8302
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.mresist.eu
 Total cost 4˙034˙222 €
 EC max contribution 4˙034˙222 € (100%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
 Code Call H2020-PHC-2014-single-stage
 Funding Scheme RIA
 Starting year 2015
 Duration (year-month-day) from 2015-01-01   to  2017-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FUNDACIO TICSALUT ES (MATARO BARCELONA) coordinator 366˙250.00
2    INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM BE (LEUVEN) participant 606˙250.00
3    The Gertner Institute for Epidemiology & Health Policy Research, Ltd IL (Ramat Gan) participant 532˙875.00
4    IBM GLOBAL SERVICES ESPANA SA ES (MADRID) participant 422˙875.00
5    FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU ES (BARCELONA) participant 348˙927.00
6    ATHENS TECHNOLOGY CENTER ANONYMI BIOMICHANIKI EMPORIKI KAI TECHNIKI ETAIREIA EFARMOGON YPSILIS TECHNOLOGIAS EL (ATHINA) participant 334˙375.00
7    AB.ACUS SRL IT (MILANO) participant 294˙875.00
8    PARC SANITARI SANT JOAN DE DEU ES (SANT BOI DE LLOBREGAT) participant 289˙543.00
9    INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS EL (ATHINA) participant 279˙125.00
10    OULUN YLIOPISTO FI (OULU) participant 232˙250.00
11    SEMMELWEIS EGYETEM HU (BUDAPEST) participant 173˙500.00
12    AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA ES (BARCELONA) participant 153˙375.00
13    IMINDS BE (GENT) participant 0.00

Map

 Project objective

In European Union approximately 5 million people suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant. These patients present persistent positive symptomatology, require extensive periods of hospital care, and have a greater risk of excess mortality and multi-morbidity. In addition, a high proportion of the total cost for treating schizophrenia is spent on this population (Kennedy et al., 2013). Intervention strategies based on mHealth have demonstrated their ability to support and promote self-management-based strategies. Evidence from studies point to the importance of engaging patients actively in their own treatment. This active role helps to improve adherence to treatment, and to reduce persistent symptoms severity, relapses and hospitalizations (Mueser et al., 2002). m-RESIST aims to develop an intervention programme based on mHealth to allow patients suffering from resistant schizophrenia to self-manage their condition (resistant schizophrenia and its associated comorbidities, e.g. somatic disorders and addictions). This may facilitate acceptance and involvement of patients with their own treatment, as well as of caregivers. Moreover this programme could provide a new tool to the psychiatrist, psychologists working together with other health care professionals, to better monitor patients, through a personalised and optimised therapeutic process. m-resist will (1) develop and validate an mHealth solution aimed to reduce the severity of episodes and further complications; (2) involve and promote participation of patients and caregivers in the therapeutic process increasing the awareness of patient and caregiver about the nature of the illness and its consequences, benefits of treatment and needs for healthy habits and promoting an active and collaborative role with the medical team in the treatment decision-making procedure.

 Deliverables

List of deliverables.
Lessons learned, guidelines and requirements for future deployment of m-RESIST Documents, reports 2019-02-22 13:10:58
m-RESIST prototype V0 Demonstrators, pilots, prototypes 2019-02-22 13:10:53
m-RESIST website Websites, patent fillings, videos etc. 2019-02-22 13:10:50
m-RESIST prototype V1 Demonstrators, pilots, prototypes 2019-03-06 09:59:23
Final Project Report including Overall Assessment Documents, reports 2019-02-25 12:36:10

Take a look to the deliverables list in detail:  detailed list of m-RESIST deliverables.

 Publications

year authors and title journal last update
List of publications.
2016 J. Seppala, H. Korpela, E. Jääskeläinen, J. Miettunen, M. Isohanni, J. Auvinen, T. Nordström, R. Marttila, S. Keinänen-Kiukaanniemi, M.R. Järvelin, H. Salo, N. Rautio
Somatic comorbidity and its outcomes in schizophrenia during lifespan
published pages: S35-S36, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2016.01.870
European Psychiatry 33 2019-05-29
2016 Nina Rautio, Juha Käkelä, Tanja Nordström, Jouko Miettunen, Sirkka Keinänen-Kiukaanniemi, Leena Ala-Mursula, Jaro Karppinen, Matti Penttilä, Erika Jääskeläinen
Prognosis of schizophrenia spectrum disorder may not be predetermined during early development – the Northern Finland Birth Cohort 1966
published pages: 62-68, ISSN: 0920-9964, DOI: 10.1016/j.schres.2016.02.038
Schizophrenia Research 173/1-2 2019-05-29
2016 K. Rubinstein
Treatment-resistant schizophrenia during life span : Epidemiology, outcomes and innovative M-Health treatments within M-RESIST Project
published pages: S35, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2016.01.869
European Psychiatry 33 2019-05-29
2016 A. Seppälä, J. Miettunen, N. Hirvonen, M. Isohanni, J. Moilanen, H. Koponen, J. Seppälä, E. Jääskeläinen
What do we know about treatment-resistant schizophrenia? – A systematic review
published pages: S586, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2016.01.2175
European Psychiatry 33 2019-05-29
2017 A. Seppälä, J. Miettunen, M. Isohanni, A. Ahmed, E. Grasa, I. Corripio, H. Koponen, J. Seppälä ,E. Jääskeläinen Kinga Farkas Iluminada Corripio
6th European Conference on Schizophrenia Research: Advancing Research—Promoting Recovery
published pages: 1-108, ISSN: 0940-1334, DOI: 10.1007/s00406-017-0824-8
European Archives of Psychiatry and Clinical Neuroscience 267/S1 2019-05-29
2016 Annika Seppälä, Conrad Molins, Jouko Miettunen, Noora Hirvonen, Iluminada Corripio, Teija Juola, Matti Isohanni, Hannu Koponen, Jani Moilanen, Jussi Seppälä, Erika Jääskeläinen and m-RESIST GROUP
What do we know about treatment-resistant schizophrenia? A systematic review.
published pages: , ISSN: 0079-7227, DOI:
Psychiatria Fennica 2016 47 2019-05-29
2017 M. Bulgheroni
Emerging sensor-based m-health interventions in the assessment of psychotic symptoms
published pages: S67, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2017.01.071
European Psychiatry 41 2019-05-29
2017 Elena Huerta Ramos, Silvia Marcó García, Maria Soledad Escobar Villegas, Elena Rubio Abadal, Susana Ochoa, Eva Grasa Bello, Anna Alonso Solís, Mireia Rabella, Jesús Berdun, Margarita Hospedales, Group m-RESIST, Iluminada Corripio Collado, Judith Usall i Rodié
m-RESIST, una solución m-Health integral para personas con Esquizofrenia Resistente estudio cualitativo de necesidades y aceptabilidad de usuarios en el área de Barcelona[1]
published pages: , ISSN: 1139-9287, DOI:
Actas Españolas de Psiquiatría 45(6) 2019-05-29
2017 Johanna Immonen, Erika Jääskeläinen, Hanna Korpela, Jouko Miettunen
Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis
published pages: 453-460, ISSN: 1751-7885, DOI: 10.1111/eip.12412
Early Intervention in Psychiatry 11/6 2019-05-29
2017 K. Rubinstein
Identifying service and care needs from the users’ perspective in treatment-resistant schizophrenia
published pages: S68, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2017.01.072
European Psychiatry 41 2019-05-29
2016 Elena Huerta-Ramos, Maria Soledad Escobar-Villegas, Katya Rubinstein, Zsolt Szabolcs Unoka, Eva Grasa, Margarita Hospedales, Erika Jääskeläinen, Elena Rubio-Abadal, Asaf Caspi, István Bitter, Jesus Berdun, Jussi Seppälä, Susana Ochoa, Kata Fazekas, Iluminada Corripio, Judith Usall
Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study
published pages: e112, ISSN: 2291-5222, DOI: 10.2196/mhealth.5716
JMIR mHealth and uHealth 4/3 2019-05-29
2017 Juha Käkelä, Riikka Marttila, Emmi Keskinen, Juha Veijola, Matti Isohanni, Heli Koivumaa-Honkanen, Marianne Haapea, Erika Jääskeläinen, Jouko Miettunen
Association between family history of psychiatric disorders and long-term outcome in schizophrenia – The Northern Finland Birth Cohort 1966 study
published pages: 16-22, ISSN: 0165-1781, DOI: 10.1016/j.psychres.2016.12.040
Psychiatry Research 249 2019-05-29
2017 I. Corripio
m-RESIST project as an example of m-health approach in schizophrenia: Content, aims and realization
published pages: S68, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2017.01.073
European Psychiatry 41 2019-05-29
2017 Nina Rautio, Jouko Miettunen, Erika Jääskeläinen, Tanja Nordström, Matti Isohanni, Jussi Seppälä
Do adverse perinatal events predict mortality in schizophrenia during midlife?
published pages: 23-29, ISSN: 0920-9964, DOI: 10.1016/j.schres.2016.09.031
Schizophrenia Research 179 2019-05-29
2016 C. Molins, A. Roldán, I. Corripio, M. Isohanni, J. Miettunen, J. Seppälä, A. Seppälä, H. Koponen, J. Moilanen, E. Jääskeläinen
Response to antipsychotic drugs in treatment-resistant schizophrenia: Conclusions based on systematic review
published pages: 64-67, ISSN: 0920-9964, DOI: 10.1016/j.schres.2016.09.016
Schizophrenia Research 178/1-3 2019-05-29
2017 J. Seppala, J. Miettunen, E. Jääskeläinen, M. Isohanni, A. Seppälä, H. Koponen
Definition, epidemiology, clinical course and outcomes in treatment-resistant schizophrenia
published pages: S67, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2017.01.070
European Psychiatry 41 2019-05-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "M-RESIST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "M-RESIST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.)

WellCO (2017)

Wellbeing and Health Virtual Coach

Read More  

EMPATHIC (2017)

Empathic, Expressive, Advanced Virtual Coach to Improve Independent Healthy-Life-Years of the Elderly

Read More  

STARR (2016)

Decision SupporT and self-mAnagement system for stRoke survivoRs

Read More